advancing innovation to save lives

GHTC director profiled in Impact Magazine

GHTC Director Jamie Bay Nishi was profiled in an article by Impact Magazine, covering challenges facing global health research and development (R&D) and the coalition's efforts to better inform policy makers.
View

Return on innovation

A new report from GHTC examines the impact of US government investment in global health R&D at home and abroad, from delivering lifesaving tools for the world’s most vulnerable people to generating economic and security returns for the United States.
 
Learn More

Johns Hopkins Center for Health Security

The Johns Hopkins Center for Health Security has published the first working definition of Global Catastrophic Biological Risks (GCBRs) to place new focus on a special category of biological risks that have received too limited research and effort given their potential for harm to humanity.

Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Patrick McKern
The Hill publishes op-ed by GHTC director

In an op-ed in The Hill, GHTC Director Kaitlin Christenson, along with Jim Connoly, President and CEO of Aeras, and Dr. Mel Spigelman, President and CEO of TB Alliance, express concerns about declining funding for global health R&D. They argue that with more products entering late-stage development, it is critical that governments continue to invest to get these products across the finish line.

View
PATH/Patrick McKern
GHTC director reflects on game-changing HIV/AIDS treatments in ONE Blog

In a post on ONE Blog, GHTC Director Kaitlin Christenson reflects on progress in developing new interventions to combat HIV/AIDS as a result of leadership from the US government.

View
View All News & Events

Community Event

Research!America
Straight Talk: 2017 Health Research Forum
Research!America
Learn More

Community Event

United Nations
72nd Session of the UN General Assembly (UNGA 72)
United Nations
Learn More
View All Events
CDC/ James Gathany
Research Roundup: Mosquito traps and the impact of antibiotics

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Mike Wang
Research Roundup: Next generation technologies for vector control, tracking Zika, and treating resistant TB

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide